Form EFFECT - Notice of Effectiveness

Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

Form EFFECT - Notice of Effectiveness

Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Affimed NV Charts.

Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Affimed NV Charts.

News Affimed NV

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 17 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)
Dienstag 17 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
Montag 9 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination with Atezolizumab in Non-Small Cell Lung Cancer
Montag 9 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients
Sonntag 8 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)
Donnerstag 5 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 14 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Affimed Reports Third Quarter 2024 Financial Results & Business Update
Donnerstag 14 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Dienstag 12 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 8 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024
Mittwoch 6 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Affimed Announces Acceptance of Three Abstracts at the 2024 ASH Annual Meeting Including an Oral Presentation Underscoring Advancing Clinical Pipeline in Leukemia and Lymphoma
Dienstag 5 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Affimed NV News-Artikel

Invesco QQQ Trust Series 1

Financial Select Sector

Deutsche Telekom

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen